ALDH1A1 Is a Novel EZH2 Target Gene in Epithelial Ovarian Cancer Identified by Genome-Wide Approaches
Hua Li(Hyupsung University), Rugang Zhang(The University of Texas MD Anderson Cancer Center), Michael Slifker(Fox Chase Cancer Center), Marie E. Maradeo(Fox Chase Cancer Center), Peter J. Tummino(Intarcia Therapeutics (United States)), Caretha L. Creasy, Michael J. Birrer(University of Arkansas Medical Center), Vinod Vathipadiekal(Wave Life Sciences (United States)), Paul Cairns(Johns Hopkins University), Benjamin G. Bitler(University of Colorado Denver)
Cited by 51
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k